Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAU 2017 | Are combination therapies the future of renal cell carcinoma treatment?

Grant Stewart, MBChB, FRCSEd (Urol), PhD, from the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, discusses novel treatments for renal cell carcinoma (RCC) at the European Association of Urology (EAU) conference 2017 in London, UK. He highlights the efficacy of combination therapies which can enhance the efficacy of known drugs. Dr Stewart also describes challenges associated with having multiple combination approaches available, and speaks about new approaches to identify good drug combinations.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.